Results 141 to 150 of about 19,047 (182)

Oncolytic virus VG161 offers new hope for refractory liver cancer. [PDF]

Front Oncol
Li J, Zhou H, Wang X, Huang K, Wang Y.
europepmc   +1 more source

Efficacy, Safety and Predictive Biomarkers of Oncolytic Virus Therapy in Solid Tumors: A Systematic Review and Meta-Analysis. [PDF]

Vaccines (Basel)
El-Tanani M, Rabbani SA, Patni MA, Babiker R, Satyam SM, Rangraze IR, Wali AF, El-Tanani Y, Porntaveetus T.   +8 more
europepmc   +1 more source

Myeloid-derived suppressor cells inhibit the replication of oncolytic virus by reducing intratumoral arginine levels. [PDF]

Mol Ther Oncol
Dryja P, Flores EB, Bartee MY, Palanisamy V, Bartee E.   +4 more
europepmc   +1 more source

KLS-3021, a multifunctional oncolytic virus, demonstrates potent early-intervention efficacy in preclinical models of prostate-confined and locally advanced prostate cancer. [PDF]

Front Oncol
Seo J, Park K, Lee S, Kang H, Kim J, Lee E, Shin J, Hong SO, Kim S, Kim SJ.   +9 more
europepmc   +1 more source

Global landscape of oncolytic virus clinical trials for pancreatic cancer: challenges and opportunities. [PDF]

Int J Surg
Yang Y, Ma Y, Tan J, Huang Z.
europepmc   +1 more source

Oncolytic virus OVV-03 enhances CAR-T cell therapy against glioblastoma via immune modulation and specific HER2 upregulation. [PDF]

Oncoimmunology
Tang Y, E Q, Ma L, Li X, Zhang Y, Wang W, Jiang Z, Zhang X, Hou Y, Du J, Zhu Y, Dong H, Xu Y, Tian T, Cheng L, Ma Q, Li J, Zhou G, Huang Y.   +18 more
europepmc   +1 more source

Engineered oncolytic virus armed with anti-PCSK9 scFv boosts long-term CD8⁺ T cell immunity via rewiring MHC-I antigen presentation. [PDF]

Cell Rep Med
Feng H, Zhang Y, Huang Z, Zhou J, Liu Y, Xiao X, Chen M, Guo X, Zheng J, Lyu Z, Hu W, Wu D, Li Y, Xing F.   +13 more
europepmc   +1 more source

Oncolytic virus M1 reinvigorates CD8⁺ T-cell immunity against glioblastoma through B-cell-dependent antigen cross-presentation in the spleen. [PDF]

Cell Mol Immunol
Han Y, Guo C, Chen C, Yang W, Li H, He C, Deng J, Chen Z, Liu W, Chen J, Zhong Y, Yan C, Xu C, Liang X, Zhong S, Chen F, Li D, Li C, Hu W, Chen Z, Mou Y, Chen Z, Yan G, Lim M, Zhu W, Sai K.   +25 more
europepmc   +1 more source

IRE1α modulates M1 oncolytic virus sensitivity via ER stress regulation in bladder cancer. [PDF]

Cancer Drug Resist
Hu C, Wei S, Zhu W, Lv B, Li S, Liu B, Yan G, Liu Y.   +7 more
europepmc   +1 more source

IP6K2 mutations as a novel mechanism of resistance to oncolytic virus therapy. [PDF]

J Transl Med
Huang Z, Zhao X, Jiang Z, Qiu X, Sun X, Wang D, Zhang H, Chen Q, Tan R, Shen Y.   +9 more
europepmc   +1 more source